Chargement en cours...
Treatment of walking impairment in multiple sclerosis with dalfampridine
Potassium channel blockade has long been considered a potential therapeutic strategy for treatment of multiple sclerosis (MS) based on the pathophysiology of demyelinated axons. Dalfampridine, which is also known as fampridine or 4-aminopyridine (4-AP), is the potassium channel blocker that has been...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3105618/ https://ncbi.nlm.nih.gov/pubmed/21694807 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285611403960 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|